Document_And_Entity_Informatio
Document And Entity Information | 9 Months Ended | |
Nov. 01, 2014 | Nov. 19, 2014 | |
Document And Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'CHICOS FAS INC | ' |
Entity Central Index Key | '0000897429 | ' |
Current Fiscal Year End Date | '--01-31 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 1-Nov-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 152,935,126 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements Of Income (Loss) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 |
Net Sales: | ' | ' | ' | ' |
Net sales | $665,569 | $655,579 | $2,018,304 | $1,975,804 |
Net sales, percent | 100.00% | 100.00% | 100.00% | 100.00% |
Cost of goods sold | 301,776 | 291,569 | 920,148 | 868,808 |
Cost of goods sold, percent | 45.30% | 44.50% | 45.60% | 44.00% |
Gross margin | 363,793 | 364,010 | 1,098,156 | 1,106,996 |
Gross margin, percent | 54.70% | 55.50% | 54.40% | 56.00% |
Selling, general and administrative expenses | 321,574 | 308,528 | 945,360 | 899,689 |
Selling, general and administrative expenses, percent | 48.30% | 47.10% | 46.80% | 45.50% |
Goodwill and trade name impairment charges | 0 | 72,466 | 0 | 72,466 |
Goodwill and trade name impairment charges, percent | 0.00% | 11.00% | 0.00% | 3.70% |
Acquisition and integration costs | 0 | 0 | 0 | 914 |
Acquisition and integration costs, percent | 0.00% | 0.00% | 0.00% | 0.00% |
Income (loss) from operations | 42,219 | -16,984 | 152,796 | 133,927 |
Income from operations, percent | 6.40% | -2.60% | 7.60% | 6.80% |
Interest income, net | 44 | 105 | 75 | 404 |
Interest income (expense), net, percent | 0.00% | 0.00% | 0.00% | 0.00% |
Income (loss) before income taxes | 42,263 | -16,879 | 152,871 | 134,331 |
Income before income taxes, percent | 6.40% | -2.60% | 7.60% | 6.80% |
Income tax provision | 15,800 | 11,600 | 56,400 | 68,100 |
Income tax provision, percent | 2.40% | 1.70% | 2.80% | 3.40% |
Net income (loss) | 26,463 | -28,479 | 96,471 | 66,231 |
Net income, percent | 4.00% | -4.30% | 4.80% | 3.40% |
Per share data: | ' | ' | ' | ' |
Net income (loss) per common share-basic | $0.17 | ($0.18) | $0.63 | $0.41 |
Net income (loss) per common and common equivalent share–diluted | $0.17 | ($0.18) | $0.63 | $0.41 |
Weighted average common shares outstanding–basic | 148,564 | 155,228 | 148,577 | 156,662 |
Weighted average common and common equivalent shares outstanding–diluted | 149,037 | 155,228 | 149,093 | 157,604 |
Dividends declared per share | $0 | $0 | $0.23 | $0.17 |
Chico's/Soma Intimates [Member] | ' | ' | ' | ' |
Net Sales: | ' | ' | ' | ' |
Net sales | 418,230 | 415,819 | 1,290,239 | 1,255,214 |
Net sales, percent | 62.90% | 63.40% | 63.90% | 63.50% |
White House | Black Market [Member] | ' | ' | ' | ' |
Net Sales: | ' | ' | ' | ' |
Net sales | 224,552 | 218,200 | 655,639 | 643,688 |
Net sales, percent | 33.70% | 33.30% | 32.50% | 32.60% |
Boston Proper [Member] | ' | ' | ' | ' |
Net Sales: | ' | ' | ' | ' |
Net sales | $22,787 | $21,560 | $72,426 | $76,902 |
Net sales, percent | 3.40% | 3.30% | 3.60% | 3.90% |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 |
Statement of Comprehensive Income [Abstract] | ' | ' | ' | ' |
Net income (loss) | $26,463 | ($28,479) | $96,471 | $66,231 |
Other comprehensive income (loss): | ' | ' | ' | ' |
Unrealized gains (losses) on marketable securities, net of taxes | -29 | 70 | -81 | -81 |
Foreign currency translation adjustment, net of taxes | 119 | 10 | 116 | 10 |
Comprehensive income (loss) | $26,553 | ($28,399) | $96,506 | $66,160 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Nov. 01, 2014 | Feb. 01, 2014 | Nov. 02, 2013 |
In Thousands, unless otherwise specified | |||
Current Assets: | ' | ' | ' |
Cash and cash equivalents | $67,172 | $36,444 | $52,524 |
Marketable securities, at fair value | 124,042 | 116,002 | 197,235 |
Inventories | 294,234 | 238,145 | 267,430 |
Prepaid expenses and other current assets | 52,062 | 50,698 | 55,835 |
Total Current Assets | 537,510 | 441,289 | 573,024 |
Property and Equipment, net | 641,187 | 631,050 | 635,284 |
Other Assets: | ' | ' | ' |
Goodwill | 171,427 | 171,427 | 171,427 |
Other intangible assets, net | 114,927 | 118,196 | 119,269 |
Other assets, net | 12,897 | 9,229 | 9,252 |
Total Other Assets | 299,251 | 298,852 | 299,948 |
Total Assets | 1,477,948 | 1,371,191 | 1,508,256 |
Current Liabilities: | ' | ' | ' |
Accounts payable | 162,641 | 131,254 | 152,698 |
Other current and deferred liabilities | 145,972 | 142,073 | 121,796 |
Total Current Liabilities | 308,613 | 273,327 | 274,494 |
Noncurrent Liabilities: | ' | ' | ' |
Deferred liabilities | 146,715 | 138,874 | 143,991 |
Deferred taxes | 42,306 | 49,887 | 53,338 |
Total Noncurrent Liabilities | 189,021 | 188,761 | 197,329 |
Stockholders’ Equity: | ' | ' | ' |
Preferred stock | 0 | 0 | 0 |
Common stock | 1,529 | 1,522 | 1,588 |
Additional paid-in capital | 401,110 | 382,088 | 372,325 |
Retained earnings | 577,528 | 525,381 | 662,375 |
Accumulated other comprehensive income | 147 | 112 | 145 |
Total Stockholders’ Equity | 980,314 | 909,103 | 1,036,433 |
Total liabilities and stockholders' equity | $1,477,948 | $1,371,191 | $1,508,256 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements Of Cash Flows (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 |
Cash Flows From Operating Activities: | ' | ' |
Net income (loss) | $96,471 | $66,231 |
Adjustments to reconcile net income to net cash provided by operating activities — | ' | ' |
Goodwill and trade name impairment charges | 0 | 72,466 |
Depreciation and amortization | 90,514 | 88,123 |
Deferred tax (benefit) expense | -9,204 | 6,024 |
Stock-based compensation expense | 20,041 | 19,542 |
Excess tax benefit from stock-based compensation | -1,654 | -1,281 |
Deferred rent and lease credits | -13,754 | -13,299 |
Loss on disposal and impairment of property and equipment | 757 | 1,432 |
Changes in assets and liabilities: | ' | ' |
Inventories | -56,089 | -60,581 |
Prepaid expenses and other assets | -5,032 | -1,775 |
Accounts payable | 31,387 | 23,311 |
Accrued and other liabilities | 27,655 | -25,087 |
Net cash provided by operating activities | 181,092 | 175,106 |
Cash Flows From Investing Activities: | ' | ' |
Purchases of marketable securities | -81,134 | -90,669 |
Proceeds from sale of marketable securities | 73,062 | 165,852 |
Purchases of property and equipment, net | -98,084 | -113,376 |
Net cash used in investing activities | -106,156 | -38,193 |
Cash Flows From Financing Activities: | ' | ' |
Proceeds from issuance of common stock | 5,930 | 10,176 |
Excess tax benefit from stock-based compensation | 1,654 | 1,281 |
Dividends paid | -34,329 | -26,536 |
Repurchase of common stock | -17,579 | -126,179 |
Net cash used in financing activities | -44,324 | -141,258 |
Effects of exchange rate changes on cash and cash equivalents | 116 | 10 |
Net increase (decrease) in cash and cash equivalents | 30,728 | -4,335 |
Cash and Cash Equivalents, Beginning of period | 36,444 | 56,859 |
Cash and Cash Equivalents, End of period | 67,172 | 52,524 |
Supplemental Disclosures of Cash Flow Information: | ' | ' |
Cash paid for interest | 230 | 269 |
Cash paid for income taxes, net | $48,321 | $62,162 |
Basis_Of_Presentation
Basis Of Presentation | 9 Months Ended |
Nov. 01, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The accompanying unaudited condensed consolidated financial statements of Chico’s FAS, Inc. and its wholly-owned subsidiaries (collectively, the “Company”) have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the U.S. (“U.S. GAAP”) for complete financial statements. In the opinion of management, such interim financial statements reflect all normal, recurring adjustments considered necessary to present fairly the condensed consolidated financial position, the results of operations and cash flows for the interim periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. For further information, refer to the consolidated financial statements and notes thereto for the fiscal year ended February 1, 2014, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 14, 2014. | |
As used in this report, all references to “we,” “us,” “our,” and “the Company,” refer to Chico’s FAS, Inc. and all of its wholly-owned subsidiaries. | |
Our fiscal years end on the Saturday closest to January 31 and are designated by the calendar year in which the fiscal year commences. Operating results for the thirteen weeks and thirty-nine weeks ended November 1, 2014 are not necessarily indicative of the results that may be expected for the entire year. |
New_Accounting_Pronouncements
New Accounting Pronouncements | 9 Months Ended |
Nov. 01, 2014 | |
Accounting Changes and Error Corrections [Abstract] | ' |
New Accounting Pronouncements | ' |
New Accounting Pronouncements | |
In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, Revenue from Contracts with Customers. The update outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for interim and annual reporting periods beginning after December 15, 2016. The standard allows for either a full retrospective or a modified retrospective transition method. We are currently assessing the potential impact of adopting this ASU, but do not, at this time, anticipate a material impact to our consolidated results of operations, financial position or cash flows. |
StockBased_Compensation
Stock-Based Compensation | 9 Months Ended | ||||||
Nov. 01, 2014 | |||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||
Stock-Based Compensation | ' | ||||||
Stock-Based Compensation | |||||||
For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, stock-based compensation expense was $20.0 million and $19.5 million, respectively. As of November 1, 2014, approximately 7.4 million shares remain available for future grants of equity awards under our 2012 Omnibus Stock and Incentive Plan. | |||||||
Restricted Stock Awards | |||||||
Restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 3,883,134 | $ | 15.13 | ||||
Granted | 1,625,050 | 16.47 | |||||
Vested | (1,195,585 | ) | 15.05 | ||||
Forfeited | (311,665 | ) | 16.23 | ||||
Unvested, end of period | 4,000,934 | 15.61 | |||||
Performance-based restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 17,222 | $ | 13.69 | ||||
Granted | — | — | |||||
Vested | (17,222 | ) | 13.69 | ||||
Forfeited | — | — | |||||
Unvested, end of period | — | — | |||||
Performance-based Restricted Stock Units | |||||||
For the thirty-nine weeks ended November 1, 2014, we granted performance-based restricted stock units (“PSUs”), contingent upon the achievement of a Company-specific performance goal during fiscal 2014. Any units earned as a result of the achievement of this goal will vest over 3 years from the date of grant and will be settled in shares of our common stock. | |||||||
Performance-based restricted stock unit activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 485,935 | $ | 15.01 | ||||
Granted | 657,000 | 16.51 | |||||
Vested | (240,596 | ) | 15.01 | ||||
Forfeited | (55,352 | ) | 15.72 | ||||
Unvested, end of period | 846,987 | 16.13 | |||||
Stock Option Awards | |||||||
For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, we did not grant any stock options. In the years that we granted options, we used the Black-Scholes option-pricing model to value our stock options. | |||||||
Stock option activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Exercise Price | |||||||
Outstanding, beginning of period | 2,642,269 | $ | 15.63 | ||||
Granted | — | — | |||||
Exercised | (288,661 | ) | 11.98 | ||||
Forfeited or expired | (272,146 | ) | 19.78 | ||||
Outstanding, end of period | 2,081,462 | 15.59 | |||||
Exercisable at November 1, 2014 | 2,051,300 | $ | 15.67 | ||||
Impairment_Charges
Impairment Charges | 9 Months Ended |
Nov. 01, 2014 | |
Asset Impairment Charges [Abstract] | ' |
Impairment Charges | ' |
Impairment Charges | |
On September 19, 2011, we acquired all of the outstanding equity of Boston Proper, Inc. (“Boston Proper”), a privately held online and catalog retailer of distinctive women’s apparel and accessories. Total cash consideration was approximately $214 million. We allocated the purchase price to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date, with the remaining unallocated purchase price recorded as goodwill. | |
In the third quarter of 2013, due to sales declines in the Boston Proper catalog business due to the increasingly competitive direct-to-consumer environment and the impact of integration efforts and new initiatives, we determined that certain Boston Proper intangibles were impaired and recorded a goodwill impairment charge of $67.3 million, reducing the carrying value of Boston Proper goodwill to $74.6 million and an impairment charge related to the Boston Proper trade name of $5.2 million pre-tax, reducing the carrying value of the Boston Proper trade name to $46.0 million. |
Earnings_Per_Share
Earnings Per Share | 9 Months Ended | |||||||||||||||
Nov. 01, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Earnings Per Share | ' | |||||||||||||||
Earnings Per Share | ||||||||||||||||
In accordance with relevant accounting guidance, unvested share-based payment awards that include non-forfeitable rights to dividends, whether paid or unpaid, are considered participating securities. As a result, such awards are required to be included in the calculation of earnings per common share pursuant to the “two-class” method. For us, participating securities are composed entirely of unvested restricted stock awards and PSUs that have met their relevant performance criteria. | ||||||||||||||||
Earnings per share (“EPS”) is determined using the two-class method, as it is more dilutive than the treasury stock method. Basic EPS excludes dilution and is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period, including participating securities. Diluted EPS reflects the dilutive effect of potential common shares from non-participating securities such as stock options and PSUs. | ||||||||||||||||
The following table sets forth the computation of basic and diluted EPS shown on the face of the accompanying condensed consolidated statements of income (loss) (in thousands, except per share amounts): | ||||||||||||||||
Thirty-Nine Weeks Ended | Thirteen Weeks Ended | |||||||||||||||
November 1, 2014 | November 2, 2013 | November 1, 2014 | November 2, 2013 | |||||||||||||
Numerator | ||||||||||||||||
Net income (loss) | $ | 96,471 | $ | 66,231 | $ | 26,463 | $ | (28,479 | ) | |||||||
Net income and dividends declared allocated to participating securities | (2,648 | ) | (1,785 | ) | (745 | ) | — | |||||||||
Net income (loss) available to common shareholders | $ | 93,823 | $ | 64,446 | $ | 25,718 | $ | (28,479 | ) | |||||||
Denominator | ||||||||||||||||
Weighted average common shares outstanding – basic | 148,577 | 156,662 | 148,564 | 155,228 | ||||||||||||
Dilutive effect of non-participating securities | 516 | 942 | 473 | — | ||||||||||||
Weighted average common and common equivalent shares outstanding – diluted | 149,093 | 157,604 | 149,037 | 155,228 | ||||||||||||
Net income (loss) per common share: | ||||||||||||||||
Basic | $ | 0.63 | $ | 0.41 | $ | 0.17 | $ | (0.18 | ) | |||||||
Diluted | $ | 0.63 | $ | 0.41 | $ | 0.17 | $ | (0.18 | ) | |||||||
For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, 0.6 million and 1.0 million potential shares of common stock, respectively, were excluded from the diluted per share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive. | ||||||||||||||||
For the thirteen weeks ended November 1, 2014 and November 2, 2013, 0.5 million and 0.8 million potential shares of common stock, respectively, were excluded from the diluted per share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive. |
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | |||||||||||||||
Nov. 01, 2014 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair Value Measurements | ' | |||||||||||||||
Fair Value Measurements | ||||||||||||||||
Our financial instruments consist of cash, money market accounts, marketable securities, assets held in our non-qualified deferred compensation plan and accounts receivable and payable. Cash, accounts receivable and accounts payable are carried at cost, which approximates their fair value due to the short-term nature of the instruments. | ||||||||||||||||
Marketable securities are classified as available-for-sale and as of November 1, 2014 generally consist of corporate bonds, commercial paper, municipal bonds, and U.S. government and agency securities with $92.6 million of securities with maturity dates within one year or less and $31.4 million with maturity dates over one year and less than two years. | ||||||||||||||||
We consider all marketable securities available-for-sale, including those with maturity dates beyond 12 months, and therefore classify these securities within current assets on the condensed consolidated balance sheets as they are available to support current operational liquidity needs. Marketable securities are carried at fair value, with the unrealized holding gains and losses, net of income taxes, reflected in accumulated other comprehensive income until realized. For the purposes of computing realized and unrealized gains and losses, cost is determined on a specific identification basis. | ||||||||||||||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. Entities are required to use a three-level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. | ||||||||||||||||
The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows: | ||||||||||||||||
Level 1 | — | Unadjusted quoted prices in active markets for identical assets or liabilities | ||||||||||||||
Level 2 | — | Unadjusted quoted prices in active markets for similar assets or liabilities, or; Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or; Inputs other than quoted prices that are observable for the asset or liability | ||||||||||||||
Level 3 | — | Unobservable inputs for the asset or liability | ||||||||||||||
We measure certain financial assets at fair value on a recurring basis, including our marketable securities, which are classified as available-for-sale securities, certain cash equivalents, specifically our money market accounts, and assets held in our non-qualified deferred compensation plan. The money market accounts are valued based on quoted market prices in active markets. Our marketable securities are generally valued based on other observable inputs for those securities (including market corroborated pricing or other models that utilize observable inputs such as interest rates and yield curves) based on information provided by independent third party pricing entities, except for U.S. government securities which are valued based on quoted market prices in active markets. The investments in our non-qualified deferred compensation plan are valued using quoted market prices and are included in other assets on our condensed consolidated balance sheets. | ||||||||||||||||
From time to time, we measure certain assets at fair value on a non-recurring basis, including evaluation of long-lived assets, goodwill and other intangible assets for impairment using company-specific assumptions which would fall within Level 3 of the fair value hierarchy. During the third quarter of fiscal 2013, we recorded a $72.5 million pre-tax impairment charge related to assets measured at fair value on a non-recurring basis, comprised of $67.3 million in Boston Proper goodwill impairment and $5.2 million pre-tax in Boston Proper trade name impairment. | ||||||||||||||||
To assess the fair value of Boston Proper goodwill, we utilized both an income approach and a market approach. Inputs used to calculate the fair value based on the income approach primarily included estimated future cash flows for the catalog business, discounted at a rate that approximates a rate that would be used by a market participant. Inputs used to calculate the fair value based on the market approach included identifying multiples of sales and earnings based on guidelines for publicly traded companies and recent transactions. | ||||||||||||||||
To assess the fair value of the Boston Proper trade name, we utilized a relief from royalty approach. Inputs used to calculate the fair value of the trade name primarily included future sales projections for the catalog business, discounted at a rate that approximates a rate that would be used by a market participant and estimated royalty rate. | ||||||||||||||||
Fair value calculations contain significant judgments and estimates, which may differ from actual results due to, among other things, economic conditions, changes to the business model or changes in operating performance. | ||||||||||||||||
During the quarter ended November 1, 2014, we did not make any transfers between Level 1 and Level 2 financial assets. Furthermore, as of November 1, 2014, February 1, 2014 and November 2, 2013, we did not have any Level 3 cash equivalents or marketable securities. We conduct reviews on a quarterly basis to verify pricing, assess liquidity, and determine if significant inputs have changed that would impact the fair value hierarchy disclosure. | ||||||||||||||||
In accordance with the provisions of the guidance, we categorized our financial assets, which are valued on a recurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows: | ||||||||||||||||
Fair Value Measurements at Reporting Date Using | ||||||||||||||||
Balance as of November 1, 2014 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||||
(in thousands) | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 2,721 | $ | 2,721 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 22,103 | — | 22,103 | — | ||||||||||||
U.S. government securities | 1,403 | 1,403 | — | — | ||||||||||||
U.S. government agencies | 20,313 | — | 20,313 | — | ||||||||||||
Corporate bonds | 49,225 | — | 49,225 | — | ||||||||||||
Commercial paper | 30,998 | — | 30,998 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 8,085 | 8,085 | — | — | ||||||||||||
Total | $ | 134,848 | $ | 12,209 | $ | 122,639 | $ | — | ||||||||
Balance as of February 1, 2014 | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 7,509 | $ | 7,509 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 51,519 | — | 51,519 | — | ||||||||||||
U.S. government securities | 9,812 | 9,812 | — | — | ||||||||||||
U.S. government agencies | 9,020 | — | 9,020 | — | ||||||||||||
Corporate bonds | 45,651 | — | 45,651 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 6,299 | 6,299 | — | — | ||||||||||||
Total | $ | 129,810 | $ | 23,620 | $ | 106,190 | $ | — | ||||||||
Balance as of November 2, 2013 | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 17,291 | $ | 17,291 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 81,963 | — | 81,963 | — | ||||||||||||
U.S. government securities | 32,194 | 32,194 | — | — | ||||||||||||
U.S. government agencies | 9,013 | — | 9,013 | — | ||||||||||||
Corporate bonds | 74,065 | — | 74,065 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 6,246 | 6,246 | — | — | ||||||||||||
Total | $ | 220,772 | $ | 55,731 | $ | 165,041 | $ | — | ||||||||
Subsequent_Events
Subsequent Events | 9 Months Ended |
Nov. 01, 2014 | |
Subsequent Events [Abstract] | ' |
Subsequent Events | ' |
Subsequent Events | |
On November 25, 2014, we announced that our Board of Directors declared a quarterly dividend of $0.075 per share on our common stock. The dividend will be payable on December 22, 2014 to shareholders of record at the close of business on December 8, 2014. Although it is our Company’s intention to continue to pay a quarterly cash dividend in the future, any decision to pay future cash dividends will be made by the Board of Directors and will depend on future earnings, financial condition and other factors. |
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 9 Months Ended | ||||||
Nov. 01, 2014 | |||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||
Summary Of Restricted Stock Activity | ' | ||||||
Restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 3,883,134 | $ | 15.13 | ||||
Granted | 1,625,050 | 16.47 | |||||
Vested | (1,195,585 | ) | 15.05 | ||||
Forfeited | (311,665 | ) | 16.23 | ||||
Unvested, end of period | 4,000,934 | 15.61 | |||||
Performance-Based Restricted Stock | ' | ||||||
Performance-based restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 17,222 | $ | 13.69 | ||||
Granted | — | — | |||||
Vested | (17,222 | ) | 13.69 | ||||
Forfeited | — | — | |||||
Unvested, end of period | — | — | |||||
Schedule Of Performance-Based Stock Units | ' | ||||||
Performance-based restricted stock unit activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Grant Date | |||||||
Fair Value | |||||||
Unvested, beginning of period | 485,935 | $ | 15.01 | ||||
Granted | 657,000 | 16.51 | |||||
Vested | (240,596 | ) | 15.01 | ||||
Forfeited | (55,352 | ) | 15.72 | ||||
Unvested, end of period | 846,987 | 16.13 | |||||
Summary Of Stock Option Activity | ' | ||||||
Stock option activity for the thirty-nine weeks ended November 1, 2014 was as follows: | |||||||
Number of | Weighted | ||||||
Shares | Average | ||||||
Exercise Price | |||||||
Outstanding, beginning of period | 2,642,269 | $ | 15.63 | ||||
Granted | — | — | |||||
Exercised | (288,661 | ) | 11.98 | ||||
Forfeited or expired | (272,146 | ) | 19.78 | ||||
Outstanding, end of period | 2,081,462 | 15.59 | |||||
Exercisable at November 1, 2014 | 2,051,300 | $ | 15.67 | ||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 9 Months Ended | |||||||||||||||
Nov. 01, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Schedule Of Earnings Per Share | ' | |||||||||||||||
The following table sets forth the computation of basic and diluted EPS shown on the face of the accompanying condensed consolidated statements of income (loss) (in thousands, except per share amounts): | ||||||||||||||||
Thirty-Nine Weeks Ended | Thirteen Weeks Ended | |||||||||||||||
November 1, 2014 | November 2, 2013 | November 1, 2014 | November 2, 2013 | |||||||||||||
Numerator | ||||||||||||||||
Net income (loss) | $ | 96,471 | $ | 66,231 | $ | 26,463 | $ | (28,479 | ) | |||||||
Net income and dividends declared allocated to participating securities | (2,648 | ) | (1,785 | ) | (745 | ) | — | |||||||||
Net income (loss) available to common shareholders | $ | 93,823 | $ | 64,446 | $ | 25,718 | $ | (28,479 | ) | |||||||
Denominator | ||||||||||||||||
Weighted average common shares outstanding – basic | 148,577 | 156,662 | 148,564 | 155,228 | ||||||||||||
Dilutive effect of non-participating securities | 516 | 942 | 473 | — | ||||||||||||
Weighted average common and common equivalent shares outstanding – diluted | 149,093 | 157,604 | 149,037 | 155,228 | ||||||||||||
Net income (loss) per common share: | ||||||||||||||||
Basic | $ | 0.63 | $ | 0.41 | $ | 0.17 | $ | (0.18 | ) | |||||||
Diluted | $ | 0.63 | $ | 0.41 | $ | 0.17 | $ | (0.18 | ) | |||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | |||||||||||||||
Nov. 01, 2014 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Financial Assets Valued On A Recurring Basis, Based On The Priority Of The Inputs To The Valuation Technique | ' | |||||||||||||||
In accordance with the provisions of the guidance, we categorized our financial assets, which are valued on a recurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows: | ||||||||||||||||
Fair Value Measurements at Reporting Date Using | ||||||||||||||||
Balance as of November 1, 2014 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||
(Level 1) | (Level 2) | (Level 3) | ||||||||||||||
(in thousands) | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 2,721 | $ | 2,721 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 22,103 | — | 22,103 | — | ||||||||||||
U.S. government securities | 1,403 | 1,403 | — | — | ||||||||||||
U.S. government agencies | 20,313 | — | 20,313 | — | ||||||||||||
Corporate bonds | 49,225 | — | 49,225 | — | ||||||||||||
Commercial paper | 30,998 | — | 30,998 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 8,085 | 8,085 | — | — | ||||||||||||
Total | $ | 134,848 | $ | 12,209 | $ | 122,639 | $ | — | ||||||||
Balance as of February 1, 2014 | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 7,509 | $ | 7,509 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 51,519 | — | 51,519 | — | ||||||||||||
U.S. government securities | 9,812 | 9,812 | — | — | ||||||||||||
U.S. government agencies | 9,020 | — | 9,020 | — | ||||||||||||
Corporate bonds | 45,651 | — | 45,651 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 6,299 | 6,299 | — | — | ||||||||||||
Total | $ | 129,810 | $ | 23,620 | $ | 106,190 | $ | — | ||||||||
Balance as of November 2, 2013 | ||||||||||||||||
Current Assets | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market accounts | $ | 17,291 | $ | 17,291 | $ | — | $ | — | ||||||||
Marketable securities: | ||||||||||||||||
Municipal securities | 81,963 | — | 81,963 | — | ||||||||||||
U.S. government securities | 32,194 | 32,194 | — | — | ||||||||||||
U.S. government agencies | 9,013 | — | 9,013 | — | ||||||||||||
Corporate bonds | 74,065 | — | 74,065 | — | ||||||||||||
Non Current Assets | ||||||||||||||||
Deferred compensation plan | 6,246 | 6,246 | — | — | ||||||||||||
Total | $ | 220,772 | $ | 55,731 | $ | 165,041 | $ | — | ||||||||
StockBased_Compensation_Narrat
Stock-Based Compensation (Narrative) (Details) (USD $) | 9 Months Ended | |
In Thousands, except Share data in Millions, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Compensation expense related to stock-based awards | $20,041 | $19,542 |
Shares available for future grants | 7.4 | ' |
Performance Based Restricted Stock [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Stock-based awards, vesting period | '3 years | ' |
StockBased_Compensation_Summar
Stock-Based Compensation (Summary Of Restricted Stock And PSU Activity) (Details) (USD $) | 9 Months Ended |
Nov. 01, 2014 | |
Restricted Stock [Member] | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] | ' |
Unvested, beginning of period, Number of Shares | 3,883,134 |
Granted, Number of Shares | 1,625,050 |
Vested, Number of Shares | -1,195,585 |
Forfeited, Number of Shares | -311,665 |
Unvested, end of period, Number of Shares | 4,000,934 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ' |
Unvested, beginning of period, Weighted Average Grant Date Fair Value | $15.13 |
Granted, Weighted Average Grant Date Fair Value | $16.47 |
Vested, Weighted Average Grant Date Fair Value | $15.05 |
Forfeited, Weighted Average Grant Date Fair Value | $16.23 |
Unvested, end of period, Weighted Average Grant Date Fair Value | $15.61 |
Performance Based Award Activity [Member] | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] | ' |
Unvested, beginning of period, Number of Shares | 17,222 |
Granted, Number of Shares | 0 |
Vested, Number of Shares | -17,222 |
Forfeited, Number of Shares | 0 |
Unvested, end of period, Number of Shares | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ' |
Unvested, beginning of period, Weighted Average Grant Date Fair Value | $13.69 |
Granted, Weighted Average Grant Date Fair Value | $0 |
Vested, Weighted Average Grant Date Fair Value | $13.69 |
Forfeited, Weighted Average Grant Date Fair Value | $0 |
Unvested, end of period, Weighted Average Grant Date Fair Value | $0 |
Performance Based Restricted Stock [Member] | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] | ' |
Unvested, beginning of period, Number of Shares | 485,935 |
Granted, Number of Shares | 657,000 |
Vested, Number of Shares | -240,596 |
Forfeited, Number of Shares | -55,352 |
Unvested, end of period, Number of Shares | 846,987 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ' |
Unvested, beginning of period, Weighted Average Grant Date Fair Value | $15.01 |
Granted, Weighted Average Grant Date Fair Value | $16.51 |
Vested, Weighted Average Grant Date Fair Value | $15.01 |
Forfeited, Weighted Average Grant Date Fair Value | $15.72 |
Unvested, end of period, Weighted Average Grant Date Fair Value | $16.13 |
StockBased_Compensation_Summar1
Stock-Based Compensation (Summary Of Stock Option Activity) (Details) (USD $) | 9 Months Ended |
Nov. 01, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' |
Outstanding, beginning of period, Number of Shares | 2,642,269 |
Granted, Number of Shares | 0 |
Exercised, Number of Shares | -288,661 |
Forfeited or expired, Number of Shares | -272,146 |
Outstanding, end of period, Number of Shares | 2,081,462 |
Exercisable at November 1, 2014, Number of Shares | 2,051,300 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ' |
Outstanding, beginning of period, Weighted Average Exercise Price | $15.63 |
Granted, Weighted Average Exercise Price | $0 |
Exercised, Weighted Average Exercise Price | $11.98 |
Forfeited or expired, Weighted Average Exercise Price | $19.78 |
Outstanding, end of period, Weighted Average Exercise Price | $15.59 |
Exercisable at November 1, 2014, Weighted Average Exercise Price | $15.67 |
Impairment_Charges_Details
Impairment Charges (Details) (USD $) | 0 Months Ended | 3 Months Ended | ||||
Sep. 19, 2011 | Nov. 01, 2014 | Feb. 01, 2014 | Nov. 02, 2013 | Nov. 02, 2013 | Nov. 02, 2013 | |
Boston Proper [Member] | Boston Proper Trade Name [Member] | |||||
Goodwill and Intangible Asset Impairment [Line Items] | ' | ' | ' | ' | ' | ' |
Payments to acquire businesses, gross | $214,000,000 | ' | ' | ' | ' | ' |
Goodwill, impairment loss | ' | ' | ' | ' | 67,300,000 | ' |
Goodwill | ' | 171,427,000 | 171,427,000 | 171,427,000 | 74,600,000 | ' |
Impairment of intangible assets, indefinite-lived (excluding goodwill) | ' | ' | ' | ' | ' | 5,200,000 |
Indefinite-lived intangible assets (excluding goodwill) | ' | ' | ' | ' | ' | $46,000,000 |
Earnings_Per_Share_Narrative_D
Earnings Per Share (Narrative) (Details) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 |
Earnings Per Share [Abstract] | ' | ' | ' | ' |
Antidilutive securities, number of shares | 0.5 | 0.8 | 0.6 | 1 |
Earnings_Per_Share_Schedule_Of
Earnings Per Share (Schedule Of Earnings Per Share) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 |
Earnings Per Share [Abstract] | ' | ' | ' | ' |
Net income (loss) | $26,463 | ($28,479) | $96,471 | $66,231 |
Net income and dividends declared allocated to participating securities | -745 | 0 | -2,648 | -1,785 |
Net income (loss) available to common shareholders | $25,718 | ($28,479) | $93,823 | $64,446 |
Weighted average common shares outstanding–basic | 148,564 | 155,228 | 148,577 | 156,662 |
Dilutive effect of non-participating securities | 473 | 0 | 516 | 942 |
Weighted average common and common equivalent shares outstanding – diluted | 149,037 | 155,228 | 149,093 | 157,604 |
Net income per common share: Basic (in dollars per share) | $0.17 | ($0.18) | $0.63 | $0.41 |
Net income per common share: Diluted (in dollars per share) | $0.17 | ($0.18) | $0.63 | $0.41 |
Fair_Value_Measurements_Narrat
Fair Value Measurements (Narrative) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' |
Securities with maturity dates less than one year | $92,600,000 | ' | $92,600,000 | ' |
Securities with maturity dates over one year and less than two years | 31,400,000 | ' | 31,400,000 | ' |
Pre-tax impairment charge | 0 | 72,466,000 | 0 | 72,466,000 |
Boston Proper [Member] | ' | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' |
Goodwill, impairment loss | ' | 67,300,000 | ' | ' |
Boston Proper Trade Name [Member] | ' | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' |
Impairment of intangible assets, indefinite-lived (excluding goodwill) | ' | $5,200,000 | ' | ' |
Fair_Value_Measurements_Financ
Fair Value Measurements (Financial Assets Valued On A Recurring Or Non-Recurring Basis, Based On The Priority Of The Inputs To The Valuation Technique) (Details) (USD $) | Nov. 01, 2014 | Feb. 01, 2014 | Nov. 02, 2013 |
In Thousands, unless otherwise specified | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Deferred compensation plan | $8,085 | $6,299 | $6,246 |
Total | 134,848 | 129,810 | 220,772 |
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Deferred compensation plan | 8,085 | 6,299 | 6,246 |
Total | 12,209 | 23,620 | 55,731 |
Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Deferred compensation plan | 0 | 0 | 0 |
Total | 122,639 | 106,190 | 165,041 |
Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Deferred compensation plan | 0 | 0 | 0 |
Total | 0 | 0 | 0 |
Municipal Securities [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 22,103 | 51,519 | 81,963 |
Municipal Securities [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
Municipal Securities [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 22,103 | 51,519 | 81,963 |
Municipal Securities [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
U.S. Government Securities [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 1,403 | 9,812 | 32,194 |
U.S. Government Securities [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 1,403 | 9,812 | 32,194 |
U.S. Government Securities [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
U.S. Government Securities [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
U.S. Government Agencies [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 20,313 | 9,020 | 9,013 |
U.S. Government Agencies [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
U.S. Government Agencies [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 20,313 | 9,020 | 9,013 |
U.S. Government Agencies [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
Corporate Bonds [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 49,225 | 45,651 | 74,065 |
Corporate Bonds [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
Corporate Bonds [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 49,225 | 45,651 | 74,065 |
Corporate Bonds [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | 0 | 0 |
Commercial Paper [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 30,998 | ' | ' |
Commercial Paper [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | ' | ' |
Commercial Paper [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 30,998 | ' | ' |
Commercial Paper [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Marketable securities | 0 | ' | ' |
Money Market Accounts [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Cash equivalents | 2,721 | 7,509 | 17,291 |
Money Market Accounts [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Cash equivalents | 2,721 | 7,509 | 17,291 |
Money Market Accounts [Member] | Significant Other Observable Inputs (Level 2) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Cash equivalents | 0 | 0 | 0 |
Money Market Accounts [Member] | Significant Unobservable Inputs (Level 3) [Member] | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' |
Cash equivalents | $0 | $0 | $0 |
Subsequent_Events_Details
Subsequent Events (Details) (USD $) | 3 Months Ended | 9 Months Ended | 0 Months Ended | ||
Nov. 01, 2014 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 | Nov. 25, 2014 | |
Subsequent Event [Member] | |||||
Subsequent Event [Line Items] | ' | ' | ' | ' | ' |
Dividends declared per share | $0 | $0 | $0.23 | $0.17 | $0.08 |